Volume replacement in the resuscitation of trauma patients with acute hemorrhage: an umbrella review
Open Access
- 30 November 2023
- journal article
- review article
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 16 (1) , 1-11
Abstract
Background: The use of intravenous fluid therapy in patients with major trauma in prehospital settings is still controversial. We conducted an umbrella review to evaluate which is the best volume expansion in the resuscitation of a hemorrhagic shock to support the development of major trauma guideline recommendations. Methods: We searched PubMed, Embase, and CENTRAL up to September 2022 for systematic reviews (SRs) investigating the use of volume expansion fluid on mortality and/or survival. Quality assessment was performed using AMSTAR 2 and the Certainty of the evidence was assessed with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Results: We included 14 SRs investigating the effects on mortality with the comparisons: use of crystalloids, blood components, and whole blood. Most SRs were judged as critically low with slight overlapping of primary studies and high consistency of results. For crystalloids, inconsistent evidence of effectiveness in 28- to 30-day survival (primary endpoint) was found for the hypertonic saline/dextran group compared with isotonic fluid solutions with moderate certainty of evidence. Pre-hospital blood component infusion seems to reduce mortality, however, as the certainty of evidence ranges from very low to moderate, we are unable to provide evidence to support or reject its use. The blood component ratio was in favor of higher ratios among all comparisons considered with moderate to very low certainty of evidence. Results about the effects of whole blood are very uncertain due to limited and heterogeneous interventions in studies included in SRs. Conclusion: Hypertonic crystalloid use did not result in superior 28- to 30-day survival. Increasing evidence supports the scientific rationale for early use of high-ratio blood components, but their use requires careful consideration. Preliminary evidence is very uncertain about the effects of whole blood and further high-quality studies are required.Keywords
This publication has 61 references indexed in Scilit:
- The Impact of Trauma Care Systems in Low- and Middle-Income CountriesAnnual Review of Public Health, 2017
- Freeze dried plasma and fresh red blood cells for civilian prehospital hemorrhagic shock resuscitationJournal of Trauma and Acute Care Surgery, 2015
- A controlled resuscitation strategy is feasible and safe in hypotensive trauma patientsJournal of Trauma and Acute Care Surgery, 2015
- Osmotic demyelination syndrome in Intensive Care UnitIndian Journal of Critical Care Medicine, 2015
- Central pontine and extrapontine myelinolysis: a systematic reviewEuropean Journal of Neurology, 2014
- Low Titer Group O Whole Blood in Emergency SituationsShock, 2014
- Systematic review finds overlapping reviews were not mentioned in every other overviewJournal of Clinical Epidemiology, 2014
- A Randomized Controlled Pilot Trial of Modified Whole Blood versus Component Therapy in Severely Injured Patients Requiring Large Volume TransfusionsAnnals of Surgery, 2013
- High Ratios of Plasma and Platelets to Packed Red Blood Cells Do Not Affect Mortality in Nonmassively Transfused PatientsJournal of Trauma: Injury, Infection & Critical Care, 2011
- Impact of Hemorrhage on Trauma Outcome: An Overview of Epidemiology, Clinical Presentations, and Therapeutic ConsiderationsJournal of Trauma: Injury, Infection & Critical Care, 2006